Publications by authors named "David Cervi"

Claim this Profile
S
Secondary hemophagocytic syndrome after autologous hematopoietic cell transplant and immune therapy for neuroblastoma.
Rebecca Epperly, Wayne Furman, Melissa Hines, Teresa Santiago, Ying Li, David Cervi

Pediatr Blood Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genitopatellar syndrome and neuroblastoma: The multidisciplinary management of a previously unreported association.
Samantha Knight, Lisa VanHouwelingen, David Cervi, Michael R Clay, Mark Corkins

Pediatr Blood Cancer· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma.
Jana Jakubikova, David Cervi, Melissa Ooi, Kihyun Kim, Sabikun Nahar

Haematologica· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications.
Jana Jakubikova, Sophia Adamia, Maria Kost-Alimova, Steffen Klippel, David Cervi

Blood· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Micronutrients attenuate progression of prostate cancer by elevating the endogenous inhibitor of angiogenesis, platelet factor-4.
David Cervi, Brian Pak, Natalie A Venier, Linda M Sugar, Robert K Nam

BMC Cancer· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular endothelial growth factor--a positive and negative regulator of tumor growth.
Laura M Vecchiarelli-Federico, David Cervi, Mehran Haeri, Yanmei Li, Andras Nagy

Cancer Res· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of novel antigens with induced immune response in monoclonal gammopathy of undetermined significance.
Simona Blotta, Pierfrancesco Tassone, Rao H Prabhala, Piersandro Tagliaferri, David Cervi

Blood· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelets actively sequester angiogenesis regulators.
Giannoula Lakka Klement, Tai-Tung Yip, Flavia Cassiola, Lena Kikuchi, David Cervi

Blood· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumors stimulate platelet delivery of angiogenic factors in vivo: an unexpected benefit.
Giorgio Pietramaggiori, Saja S Scherer, David Cervi, Giannoula Klement, Dennis P Orgill

Am J Pathol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet-associated PF-4 as a biomarker of early tumor growth.
David Cervi, Tai-Tung Yip, Nandita Bhattacharya, Vladimir N Podust, Jon Peterson

Blood· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced natural-killer cell and erythropoietic activities in VEGF-A-overexpressing mice delay F-MuLV-induced erythroleukemia.
David Cervi, Yuval Shaked, Mehran Haeri, Tatiana Usenko, Christina R Lee

Blood· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of serum and antioxidants on the immunogenicity of protein kinase C-activated chronic lymphocytic leukemia cells.
Caitlin Hammond, Yonghong Shi, Jenny Mena, Jelena Tomic, David Cervi

J Immunother· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct transcriptional regulation of MDM2 by Fli-1.
Amandine H L Truong, David Cervi, Jane Lee, Yaacov Ben-David

Oncogene· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphorylation status of c-Kit and Epo receptors, and the presence of wild-type p53 confer in vitro resistance of murine erythroleukemic cells to Celecoxib.
David Cervi, Amandine H L Truong, Jane S Lee, Natasha Sukhai, You-Jun Li

Oncogene· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis